Contemporary Endocrinology
Metabolomic signatures and metabolic complications in childhood obesity
Publication
, Chapter
Balikcioglu, PG; Newgard, CB
January 1, 2018
Type 2 diabetes is caused by complex interactions between genetic and environmental factors. Comprehensive metabolite profiling or "metabolomics" defines the chemical phenotype of biological systems and explores their integrated responses to genetic variation and environmental changes. Thus, application of metabolomics in childhood obesity can play a key role in defining novel disease mechanisms and targets for early diabetes prevention and treatment. This chapter seeks to review the application of metabolomics to childhood obesity, insulin resistance, and type 2 diabetes.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Balikcioglu, P. G., & Newgard, C. B. (2018). Metabolomic signatures and metabolic complications in childhood obesity. In Contemporary Endocrinology (pp. 343–361). https://doi.org/10.1007/978-3-319-68192-4_21
Balikcioglu, P. G., and C. B. Newgard. “Metabolomic signatures and metabolic complications in childhood obesity.” In Contemporary Endocrinology, 343–61, 2018. https://doi.org/10.1007/978-3-319-68192-4_21.
Balikcioglu PG, Newgard CB. Metabolomic signatures and metabolic complications in childhood obesity. In: Contemporary Endocrinology. 2018. p. 343–61.
Balikcioglu, P. G., and C. B. Newgard. “Metabolomic signatures and metabolic complications in childhood obesity.” Contemporary Endocrinology, 2018, pp. 343–61. Scopus, doi:10.1007/978-3-319-68192-4_21.
Balikcioglu PG, Newgard CB. Metabolomic signatures and metabolic complications in childhood obesity. Contemporary Endocrinology. 2018. p. 343–361.